SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $51,908,643 | -21.6% | 1,940,510 | 0.0% | 0.31% | -11.8% |
| Q1 2024 | $66,190,796 | +17.9% | 1,940,510 | +0.1% | 0.35% | +0.9% |
| Q4 2023 | $56,125,223 | +23.0% | 1,939,365 | +17.2% | 0.34% | +1.8% |
| Q3 2023 | $45,613,738 | +0.9% | 1,654,470 | +10.0% | 0.34% | +48.2% |
| Q2 2023 | $45,224,368 | -10.0% | 1,504,470 | +8.4% | 0.23% | -30.1% |
| Q1 2023 | $50,266,045 | +38.3% | 1,387,415 | +36.1% | 0.33% | +12.4% |
| Q4 2022 | $36,352,010 | +35.2% | 1,019,120 | +28.3% | 0.29% | +69.6% |
| Q3 2022 | $26,881,000 | +17.0% | 794,120 | 0.0% | 0.17% | +26.7% |
| Q2 2022 | $22,966,000 | -19.1% | 794,120 | -9.5% | 0.14% | +5.5% |
| Q1 2022 | $28,375,000 | +55.0% | 877,945 | +39.8% | 0.13% | +85.5% |
| Q4 2021 | $18,311,000 | – | 627,945 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |